Search results
AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis
Pharmaceutical Technology via Yahoo Finance· 6 days agoAbbVie has announced receipt of US Food and Drug Administration (FDA) approval for SKYRIZI...
Walden Wealth Partners LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoWalden Wealth Partners LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks· 7 days agoFree Report) ending at $171.36, denoting a +0.99% adjustment from its last day's close. This change outpaced the S&P 500's 0.25% gain on the day. In that same time, the Medical sector gained ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Tri-County Times· 6 days agoAbbVie logo (PRNewsFoto/AbbVie)
Nvidia's 3-Day Loss Exceeds The Value Of 96% Of The S&P 500
Investor's Business Daily· 10 hours agoThink you had a bad day? It's nothing compared to the drop the past three trading days by S&P 500...
Humira: the highs and lows of the world’s best-selling drug
Pharmaceutical Technology via Yahoo Finance· 7 days agoHumira, an arthritis medication with indications for colitis and psoriasis is the world’s...
Here's Why You Should Consider Buying Alvotech (ALVO) Stock
Zacks via Yahoo Finance· 15 hours agoThe company recently gained approval for some key biosimilar products like AVT04, its biosimilar to...
Here's Why AbbVie (ABBV) is a Strong Momentum Stock
Zacks via Yahoo Finance· 6 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
Motley Fool via Yahoo Finance· 6 days agoUnlike growth stocks, you don't have to sell shares to receive cash. Companies that pay dividends...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 6 days agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...